Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biology and clinical observations of regulatory T cells in cancer immunology.
Teng MW, Ritchie DS, Neeson P, Smyth MJ. Teng MW, et al. Among authors: ritchie ds. Curr Top Microbiol Immunol. 2011;344:61-95. doi: 10.1007/82_2010_50. Curr Top Microbiol Immunol. 2011. PMID: 20512555 Review.
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
Ritchie D, Mileshkin L, Wall D, Bartholeyns J, Thompson M, Coverdale J, Lau E, Wong J, Eu P, Hicks RJ, Prince HM. Ritchie D, et al. Cancer Immunol Immunother. 2007 Feb;56(2):155-63. doi: 10.1007/s00262-006-0181-3. Epub 2006 May 30. Cancer Immunol Immunother. 2007. PMID: 16733671 Clinical Trial.
DC research in Australia.
Ritchie DS. Ritchie DS. Cytotherapy. 2007;9(3):225-30. doi: 10.1080/14653240701306212. Cytotherapy. 2007. PMID: 17464753 Review.
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.
Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM. Mileshkin L, et al. Haematologica. 2007 Aug;92(8):1075-82. doi: 10.3324/haematol.11208. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640854
Plasma cell lysate as an antigen source in multiple myeloma immunotherapy.
Ritchie DS. Ritchie DS. Leuk Lymphoma. 2007 Oct;48(10):1894-5. doi: 10.1080/10428190701625107. Leuk Lymphoma. 2007. PMID: 17917956 No abstract available.
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
Westwood JA, Murray WK, Trivett M, Shin A, Neeson P, MacGregor DP, Haynes NM, Trapani JA, Mayura-Guru P, Fox S, Peinert S, Honemann D, Prince HM, Ritchie D, Scott AM, Smyth FE, Smyth MJ, Darcy PK, Kershaw MH. Westwood JA, et al. Gene Ther. 2008 Jul;15(14):1056-66. doi: 10.1038/gt.2008.47. Epub 2008 Mar 27. Gene Ther. 2008. PMID: 18369322
Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?
Ritchie DS. Ritchie DS. Leuk Lymphoma. 2008 Oct;49(10):1852-3. doi: 10.1080/10428190802491714. Leuk Lymphoma. 2008. PMID: 18949608 No abstract available.
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.
Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Quach H, et al. Leukemia. 2010 Jan;24(1):22-32. doi: 10.1038/leu.2009.236. Epub 2009 Nov 12. Leukemia. 2010. PMID: 19907437 Free PMC article. Review.
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.
Peinert S, Prince HM, Guru PM, Kershaw MH, Smyth MJ, Trapani JA, Gambell P, Harrison S, Scott AM, Smyth FE, Darcy PK, Tainton K, Neeson P, Ritchie DS, Hönemann D. Peinert S, et al. Among authors: ritchie ds. Gene Ther. 2010 May;17(5):678-86. doi: 10.1038/gt.2010.21. Epub 2010 Mar 4. Gene Ther. 2010. PMID: 20200563
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.
Neeson P, Shin A, Tainton KM, Guru P, Prince HM, Harrison SJ, Peinert S, Smyth MJ, Trapani JA, Kershaw MH, Darcy PK, Ritchie DS. Neeson P, et al. Among authors: ritchie ds. Gene Ther. 2010 Sep;17(9):1105-16. doi: 10.1038/gt.2010.59. Epub 2010 Apr 29. Gene Ther. 2010. PMID: 20428216
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page